Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
about
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaZAP-70 in B cell malignanciesFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaA two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia.Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progressionUpdate on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy.Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cellsB cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy.Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia.Analysis of ZAP70 expression in adult acute lymphoblastic leukaemia by real time quantitative PCR.ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia.ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesionProtein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia.Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype.MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis.Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features.ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor
P2860
Q28248800-492EFC1F-701F-4576-8DD7-3DEAB321DADBQ28279902-5429270D-93DC-4008-8B6B-2CA5233DDCBCQ28282822-CE622E73-30BA-42EA-8CBB-E8E67CFA7AC3Q34110002-658EAB03-530C-4327-AFB8-D626250CE96EQ34253142-F2BB7E53-CADD-4240-8123-2E4F930D7F46Q34569256-9D46C878-0329-4DAE-B7EA-0635074A0639Q34924406-680E9022-3302-431E-9ABA-DEE8781B4E37Q35597328-FEFE7959-B61D-4A52-B56E-9B250D539705Q35908496-61E77213-BEBA-4A7B-AD56-5FC27B2AE90CQ35954301-085AF3B2-94CB-45F8-9723-729272655A06Q35988140-660BD860-A4B9-44D1-ADEF-FB3716A2DC50Q36857967-A82E9A60-194C-4D1F-8579-FD675445F63BQ36925185-E4A32C48-0378-4B3A-8F0D-10CDA507D2BDQ37195045-4A605351-E2FA-47AF-ADFA-896407497524Q38042778-E2F91E52-3BCF-4AE3-8F29-B6AB4F51B194Q39355631-700BC9D8-34E1-4C6C-9F84-122A28DCD0C0Q40003594-7DAACB80-76B1-4BE7-8E46-DE7ACBB2C52CQ40315561-FDE7CAE9-1417-47C3-BBF9-27E9B822CC96Q40330626-57E4E85E-CD1C-4C4A-A78B-1DAF347AC84AQ40390889-5A0C5EC2-B829-4F31-B866-D90E19C71A13Q40672789-D2FC8CE3-4C2F-46D0-9931-8EE789E6788FQ42807725-92A5021B-7F86-46BF-B861-914FBC61CDF8Q44171503-58564DAE-7503-48F0-9F27-CF9567391EBDQ45247281-D9B0B6E3-B766-4249-B5B1-88FEA5DC26B0Q46412983-CC4F98D5-0CEC-48BF-8098-D8D901FFA2E8Q53321355-659AC452-592A-4703-A0E0-60645D22FFE7Q54595876-8423A44A-50C9-4970-B9D6-EB40BABABCF6Q58042045-11718BB0-0053-4926-9542-3A760A0E666B
P2860
Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
@en
type
label
Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
@en
prefLabel
Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
@en
P2093
P2860
P1433
P1476
Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
@en
P2093
George Z Rassidakis
Joan H Admirand
Jose R Valbuena
L Jeffrey Medeiros
Lynne V Abruzzo
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800145
P577
2004-08-01T00:00:00Z
P5875
P6179
1041065372